PCI 7 November 2023, 15:22
Thermofisher: Thu 29 February 2024, 11:15
BMG Labtech: Wed 18 September 2024, 11:55
Owen Mumford 12 January 2022, 16:46

Current Edition

Cell and Gene Therapy

Upcoming Events

Biotechnology Show 2025: 20th January 2025
Anglonordic: 16th January 2025
AI in Drug Discovery – SAE media – January 14th 2025

Advertisement

Fujifilm rectangle: Fri 22 November 2024, 14:23
Roald Dahl Charity: Fri 15 November 2024, 12:57
A&M STABTEST: Fri 21 June 2024, 11:43
CDD Vault: Wed 17 July 2024, 11:46
HTI Automation: Tue 12 November 2024, 14:28
Discovery Park: Tue 17 September 2024, 10:01

The Sweet Threat

DNA, RNA and proteins are not the only ways for living organisms to encode information and to communicate. Glycoconjugates and their cognate receptors, the C-type lectins, mediate and
tune the vast majority of the biological phenomena such as cell-cell adhesion, cell proliferation or pathogen detection. The pathogens developed through evolution glycan motifs enable
them to shape to some extent the immune response, in order to build a favourable niche for their development. Alexiane Decout, a Postdoctoral Scientist at EPFL, argues that more efforts are required to decipher these interactions and translate them to new therapies.

[wonderplugin_pdf src=”https://www.biopharmaceuticalmedia.com/wp-content/uploads/2018/10/The-sweet-threat.pdf” width=”100%” height=”900px” style=”border:0;”]

Newcells 3 June 2024, 15:12
Novonordisk: Wed 17 July 2024, 11:22
FujiFilm 30 October 2023, 16:23
Eclateral 30 October 2023, 15:34
Autoscribe Mon 26 June 2023, 15:15
Aldevron: 16th January 2025
Richter: Wed 23 October 2024, 09:03
GenXPro: Mon 16 September 2024, 10:40
Biosynth: Tue 1 October 2024, 13:25